{"result": "(\"entity\"<|>IENTO<|>ORGANIZATION<|>Iento is an organization involved in medical diagnostics and treatment related to celiac disease and other gastrointestinal conditions.)\n##\n(\"entity\"<|>ENFERMEDAD CELIACA<|>EVENT<|>Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, leading to damage in the small intestine.)\n##\n(\"entity\"<|>D-XILOSA<|>ORGANIZATION<|>D-Xilosa is a monosaccharide used in medical tests to assess the integrity of the intestinal epithelium.)\n##\n(\"entity\"<|>DIETA SIN GLUTEN<|>EVENT<|>A gluten-free diet is the primary treatment for celiac disease, requiring lifelong adherence to avoid symptoms and intestinal damage.)\n##\n(\"entity\"<|>TRATAMIENTO<|>EVENT<|>Treatment for celiac disease involves dietary changes and specific nutritional guidance to manage symptoms and promote health.)\n##\n(\"entity\"<|>AC<|>ORGANIZATION<|>AC refers to antibodies that are tested in relation to celiac disease.)\n##\n(\"entity\"<|>EMA<|>ORGANIZATION<|>EMA refers to endomysial antibodies, which are significant in diagnosing celiac disease.)\n##\n(\"entity\"<|>tTG<|>ORGANIZATION<|>tTG refers to tissue transglutaminase antibodies, which are commonly tested for celiac disease diagnosis.)\n##\n(\"entity\"<|>BI<|>ORGANIZATION<|>BI refers to intestinal biopsy, a procedure used to confirm the diagnosis of celiac disease.)\n##\n(\"relationship\"<|>IENTO<|>ENFERMEDAD CELIACA<|>Iento is involved in the diagnosis and treatment of celiac disease, providing medical services related to this condition.<|>8)\n##\n(\"relationship\"<|>DIETA SIN GLUTEN<|>ENFERMEDAD CELIACA<|>The gluten-free diet is the essential treatment for managing celiac disease and preventing its symptoms.<|>9)\n##\n(\"relationship\"<|>TRATAMIENTO<|>ENFERMEDAD CELIACA<|>Treatment for celiac disease includes dietary management and nutritional counseling to ensure health and well-being.<|>8)\n##\n(\"relationship\"<|>D-XILOSA<|>ENFERMEDAD CELIACA<|>D-Xilosa is used in tests to evaluate the absorption capabilities of patients with celiac disease.<|>7)\n##\n(\"relationship\"<|>AC<|>ENFERMEDAD CELIACA<|>AC testing is part of the diagnostic process for celiac disease, helping to identify the autoimmune response.<|>8)\n##\n(\"relationship\"<|>EMA<|>ENFERMEDAD CELIACA<|>EMA testing is crucial for diagnosing celiac disease, indicating the presence of specific antibodies.<|>8)\n##\n(\"relationship\"<|>tTG<|>ENFERMEDAD CELIACA<|>tTG testing is a standard method for diagnosing celiac disease by detecting antibodies in the blood.<|>8)\n##\n(\"relationship\"<|>BI<|>ENFERMEDAD CELIACA<|>An intestinal biopsy is performed to confirm the diagnosis of celiac disease by examining intestinal tissue.<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: IENTO                                                                                                                                         ANTICUERPOS\n                                                                                                                                                                                                                                               ANEMIA FERROPENICA\n                                                                                                                                                                                                                                                                 ESTEATORREA                                                                                                                                 (EMA 0 tTG)\n                                                                                    ANTICUERPOS                                                                                                      BIOPSIA                                                                                                                                            PosITIVO\n                                                                                         (EMA 0 tTG)\n                                                                                                                                                                                                                                                                                                                                                                                                                       NEGATIVO\n                                                                AC+/BIO+                                                                                               AC+IBIO                                                                                                  AC-IBIO+                                                                                  AC-IBIO -\n                                                                                                                                                                                                                                                                     VALORAR OTRAS\n                                                                                                                                                                          VIGILAR                                                                           CAUSAS DE ATROFIA\n                                                                                                             POSITIVO                                                                 Y/O                                                                                 VELLOSITARIA                                                                                                DESCARTA\n                                                                                                                                                                         REPETIRBIOPSIA                                                                                                                                                                                     ENFERMEDAD\n                                                                                                                                                                                                                                                              NO\n                                                                                             TRATAMIENTO                                                                                     DIETA SIN GLUTEN                                                                                                                                    TRATAMIENTOSESPECIFICOS\n                                                         AC: anticuerpos; BI: biopsia Intestinal; EMA: anticuerpos endomisio; tTG: anticuerpos antitransglutaminasa.AC= Anticuerpos ,      EMA = (AC. Anti-Endomisio) ,\n                                                                                            Ttg = ( AC.Anti-Transglutaminasa), BI= Biopsia Intestinal.\n                                          Figura 2.                                     Algoritmo diagnóstico de la enfermedad celiaca.\n\n\n\nción de grasa en heces (esteatorrea), y se considera la                                                                                                                                                                                                                          mg/dl en suero a los 60 minutos. Permite diferenciar\nprimera prueba a realizar en el estudio de una malab-                                                                                                                                                                                                                            entre                             la              maldigestión                                              (epitelio                                intestinal  íntegro,\nsorción-maldigestión. La cuantificación de la grasa                                                                                                                                                                                                                              prueba de la D-xilosa normal) y la malabsorción (epi-\nfecal se realiza mediante el test de Van de Kamer, que                                                                                                                                                                                                                           telio intestinal alterado, prueba de la D-xilosa anor-\nmide el contenido fecal de ácidos grasos. En condicio-                                                                                                                                                                                                                           mal).\nnes normales, ingiriendo una dieta con un contenido\nen grasas de 60-100 g/24 h durante 3-5 días, la ex-                                                                                                                                                                                                                              6. Tratamiento dietoterápico\ncreción fecal de grasa es de 3-5 g/24 h. Cuando no se\ndispone de esta prueba se puede sospechar este diag-                                                                                                                                                                                                                                       Actualmente, el único tratamiento que ha demostra-\nnóstico por el aumento notable del peso de las heces                                                                                                                                                                                                                             do ser eficaz para la celiaquía es la adherencia a una\ndiarias (>300 g/24 h) y determinadas características                                                                                                                                                                                                                             dieta exenta de gluten para toda la vida. Así, el aspecto\nmacroscópicas como la flotabilidad. La valoración de                                                                                                                                                                                                                             terapéutico fundamental en el manejo de la EC es el\nla integridad de la mucosa intestinal se realiza con la                                                                                                                                                                                                                          consejo dietético-nutricional21. La dieta «sin gluten»\nprueba de la D-xilosa. Esta técnica mide la integridad                                                                                                                                                                                                                           exige importantes cambios en el estilo de vida asociado\ndel epitelio intestinal, dado que la D-xilosa es un mo-                                                                                                                                                                                                                          a la dieta occidental, ya que consumimos una gran va-\nnosacárido que se absorbe por difusión pasiva en el                                                                                                                                                                                                                              riedad de alimentos de uso diario como el pan, pastas\nintestino proximal, sin digestión previa. Tiene alta                                                                                                                                                                                                                             y harinas que contienen o pueden contener gluten. Por\nsensibilidad y especificidad (>90 %). Administrando                                                                                                                                                                                                                              otro lado, la cada vez más frecuente cocina industrial\n25 g de D-xilosa diluidos, se mide la xilosemia a la                                                                                                                                                                                                                             con platos precocinados y conservas, puede contener\nhora de la ingesta y la xilosuria durante las 5 horas                                                                                                                                                                                                                            gluten como conservante y esto hace necesario atraer\nposteriores a la ingesta. Los valores normales corres-                                                                                                                                                                                                                           a nuestros pacientes hacia una dieta basada en consu-\nponden a 4-8 g de xilosa en la orina de 5 horas y >20                                                                                                                                                                                                                            mo de alimentos frescos y cocina propia.\n---\n 296      BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n\n\n   Es necesario excluir de la dieta cualquier derivado                      •  «Lifelong adherence to a gluten-free diet» (La\nque contenga proteínas de los siguientes cereales: tri-                        reintroducción, voluntaria o no, del gluten en\ngo, cebada y centeno. Existen dudas en la literatura                           dieta condiciona de nuevo la reaparición de clí-\nrespecto a la toxicidad de la avena. Otros cereales po-                        nica o al menos de las lesiones morfológicas en\ntencialmente tóxicos, aunque de menor uso en nuestra                           el intestino).\nalimentación habitual, son: espelta, kamut y triticale                      •  «Identification and treatment of nutritional de-\n(híbrido de trigo y centeno). Estos se pueden sustituir                        ficiencies» (Realizar valoración de las\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}